Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Mar. 30, 2024
OPERATING ACTIVITIES      
Net income (loss) $ 254,920 $ (189,716) $ (968,882)
Income (loss) from discontinued operations, net of tax 0 (259,040) 49,595
Income (loss) from continuing operations, net of tax 254,920 69,324 (1,018,477)
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Impairment of goodwill and intangible assets 30,716 89,242 507,566
Depreciation, amortization and other asset write-downs 280,529 259,616 307,528
Reduction in the carrying amount of right-of-use assets 354,756 351,971 379,720
Stock-based compensation 76,954 73,247 57,829
Provision for doubtful accounts 9,480 15,377 11,170
Pension expense in excess of (less than) contributions 188,084 (1,463) (18,080)
Pension termination asset reversion, net 125,373 0 0
Deferred income taxes (42,249) (88,544) (383,916)
Write-off of income tax receivables and interest 0 0 921,409
Gain on sale of business (127,211) 0 0
Other, net 9,450 (9,515) (2,138)
Changes in operating assets and liabilities:      
Accounts receivable (166,709) (100,803) 323,503
Inventories 173,517 54,102 521,281
Accounts payable 26,713 (2,303) (111,992)
Income taxes (47,321) 9,366 (156,198)
Accrued liabilities (85,677) 48,847 27,539
Operating lease right-of-use assets and liabilities (350,496) (353,661) (374,063)
Other assets and liabilities (39,555) 23,686 (107,967)
Cash provided by operating activities - continuing operations 671,274 438,489 884,714
Cash provided by operating activities - discontinued operations 0 26,747 129,867
Cash provided by operating activities 671,274 465,236 1,014,581
INVESTING ACTIVITIES      
Proceeds from sale of businesses, net of cash sold 600,524 1,506,223 0
Proceeds from sale of assets 868 88,234 26,525
Capital expenditures (114,707) (86,274) (135,762)
Software purchases (51,099) (39,749) (61,483)
Other, net (28,490) (35,930) 12,038
Cash provided (used) by investing activities - continuing operations 407,096 1,432,504 (158,682)
Cash used by investing activities - discontinued operations 0 (4,413) (13,576)
Cash provided (used) by investing activities 407,096 1,428,091 (172,258)
FINANCING ACTIVITIES      
Net increase (decrease) in short-term borrowings (2,322) (252,023) 255,146
Payments on long-term debt (582,813) (1,751,109) (908,199)
Payment of debt issuance costs (12,601) 0 (576)
Cash dividends paid (140,744) (140,165) (303,140)
Proceeds from issuance of Common Stock, net of (payments) for tax withholdings 699 (2,730) (2,846)
Cash used by financing activities (737,781) (2,146,027) (959,615)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash 60,280 7,218 (22,069)
Net change in cash, cash equivalents and restricted cash 400,869 (245,482) (139,361)
Cash, cash equivalents and restricted cash — beginning of year 431,475 676,957 816,318
Cash, cash equivalents and restricted cash — end of year 832,344 431,475 676,957
Balances per Consolidated Balance Sheets:      
Cash and cash equivalents 823,943 429,382 656,376
Other current assets 8,401 2,093 2,221
Current and other assets of discontinued operations 0 0 18,351
Other assets 0 0 9
Total cash, cash equivalents and restricted cash $ 832,344 $ 431,475 $ 676,957